- Sector: Health Technology
- Industry: Pharmaceuticals: Other
Halo Labs, Inc. engages in the development and manufacture of cannabis oils and concentrates. Its operations include Oregon, Nevada, and California. The company was founded in 2016 and is headquartered in Toronto, Canada.
All figures in USD and as per BDS Analytics, Inc. unless stated otherwise TORONTO, Jan. 12, 2021 /CNW/ – Halo Labs Inc. (“Halo” or the “Company“) (NEO: HALO) (OTCQX: AGEEF) (Germany: A9KN) announces that BDS Analytics, Inc. (“BDSA”) has reported record year over year retail sales growth in November 2020 of Halo products in Oregon’s recreational cannabis market. Oregon retail sales reached $89.9 million in November […]
TORONTO, Dec. 30, 2020 /CNW/ – Halo Labs Inc. (“Halo” or the “Company“) (NEO: HALO) (OTCQX: AGEEF) (Germany: A9KN) is pleased to announce it has closed its previously announced acquisition of 1275111 B.C. Ltd. (“1275111“) on the terms described in the press release dated December 22, 2020 (the “Transaction“). Halo issued an aggregate of 147,475,343 common shares of Halo (“Halo Shares“) […]
Halo Announces Agreement to Acquire a Cannabis Processing Technology Company and Concurrent Private Placement
All figures in USD unless otherwise noted TORONTO, Dec. 22, 2020 /CNW/ – Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO) (OTCQX: AGEEF) (Germany: A9KN) is pleased to announce that it has entered into a share exchange agreement dated effective December 22, 2020 (the “Share Exchange Agreement”) with 1275111 B.C. Ltd. (“1275111”) and the shareholders of 1275111 (the “Shareholders”), […]
Something went wrong. Please refresh the page and/or try again.